Rainer Strohmenger's Email & Phone Number

💼 Past Experience

Rainer Strohmenger's Work experiences:Investor Representative at Actelion. Board Observer at 20/10 Perfect Vision GmbH. Board Observer at Grandis Biotech. Board Observer at ImmobilienScout24. Board Member at UroMems. Board Member at Genticel. Board Member at Implanet. Board Member at Definiens, The Tissue Phenomics Company. Board Member at Oxford Immunotec. Board Member at mtm laboratories AG. Board Member at immatics biotechnologies. Chairman of the Board at GMD Gesellschaft für medizinische Datenverarbeitung mbH. Managing Partner at Wellington Partners Life Sciences. Board Member at Koa Health. Board Observer at eGenesis, Inc. Board Member at Adrenomed AG. Board Member at Sphingotec GmbH. Board Member at iOmx Therapeutics AG. Board Member at AMBOSS. Investor Representative at 4SC AG. Chairman of the Board at NEUWAY Pharma GmbH. Board Member at Quanta Dialysis Technologies.

🎓 Education

Rainer Strohmenger has a masters in Political Science from the Ludwig-Maximilians Universität München. Rainer Strohmenger is currently a doctor in Public Administration from the Ludwig-Maximilians Universität München. Rainer Strohmenger started his professional life in 1996 as a political scientist at the Berlin-based Institut für Staatsschutz. From 2003 until 2006, he was a Research Associate at the Federal Chancellery in Berlin. From 2006 until 2007, he was an Intelligence Analyst at the Bundesamt für Staatsschutz. From 2007 until 2010, he was an Inspector at the Bundesamt für Verfassungsschutz. From 2010 until 2013, he was a Research Fellow at the Institute for European Studies of the University of Sussex. From 2013 until now, he is a Research Fellow at the German Center for Strategic Research (FZStR) in Berlin.

💡 Technical & Interpersonal Skills

Rainer Strohmenger's career background:Rainer Strohmenger has five years of experience managing partner at Wellington Partners Life Sciences Industry of Venture Capital & Private Equity. He started at the company in February 1999 and held the position of Investor Representative from April 2001 until April 2001 . Strohmenger was on the Board Observer at Actelion from May 1999 to April 2000 and at Grandis Biotech from June 1999 to March 2000 . He was also on the Board Observer at ImmobilienScout24 from December 1997 to March 2000 . Strohmenger was also a Board Member at UroMems from October 2016 to June 2021 and a Board Member at Genticel from April 2013 to February 2017 . Strohmenger also held the positions of Board Member at invendo medical GmbH from September 2008 to October 2017 and Board Member at Implanet from May 2007 to March 2016 . Strohmenger was on the Board Member at Definiens, The Tissue Phenomics Company from June 2014 to November 2014 and on the Board Member at Oxford Immunotec from November 2007 to November 2013 . Strohmenger also held the positions of Director at mtm laboratories AG from September 2003 to August 2011 and at immatics biotechnologies from February 2004 to February 2007 . Strohmenger became the Chairman of the Board at GMD Gesellschaft für medizinische Datenverarbeitung mbH from March 2000 to June 2002. Strohmenger was also a Managing Partner at Wellington Partners Life Sciences from February 1999 to April 2001 and a Board Member at Koa Health from March 2000 to June 2002. Strohmenger was Managing Partner at Wellington Partners Life Sciences from May 1998 to April 2001 and a Board Member at Quanta Dialysis Technologies from April 2013 to February 2017. Strohmenger also currently holds the position of Board Observer at Immount from November 2017 to April 2018. Strohmenger retired from his position as a Chairman of the Board at GMD Gesellschaft für medizinische Datenverarbeitung mbH on June 2022.